These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 34937051)

  • 21. Global absence and targeting of protective immune states in severe COVID-19.
    Combes AJ; Courau T; Kuhn NF; Hu KH; Ray A; Chen WS; Chew NW; Cleary SJ; Kushnoor D; Reeder GC; Shen A; Tsui J; Hiam-Galvez KJ; Muñoz-Sandoval P; Zhu WS; Lee DS; Sun Y; You R; Magnen M; Rodriguez L; Im KW; Serwas NK; Leligdowicz A; Zamecnik CR; Loudermilk RP; Wilson MR; Ye CJ; Fragiadakis GK; Looney MR; Chan V; Ward A; Carrillo S; ; Matthay M; Erle DJ; Woodruff PG; Langelier C; Kangelaris K; Hendrickson CM; Calfee C; Rao AA; Krummel MF
    Nature; 2021 Mar; 591(7848):124-130. PubMed ID: 33494096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
    Borges RC; Hohmann MS; Borghi SM
    Int Rev Immunol; 2021; 40(1-2):108-125. PubMed ID: 33191813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
    Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
    EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
    Boechat JL; Chora I; Morais A; Delgado L
    Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.
    Yin X; Riva L; Pu Y; Martin-Sancho L; Kanamune J; Yamamoto Y; Sakai K; Gotoh S; Miorin L; De Jesus PD; Yang CC; Herbert KM; Yoh S; Hultquist JF; García-Sastre A; Chanda SK
    Cell Rep; 2021 Jan; 34(2):108628. PubMed ID: 33440148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aging-related cell type-specific pathophysiologic immune responses that exacerbate disease severity in aged COVID-19 patients.
    Hou Y; Zhou Y; Jehi L; Luo Y; Gack MU; Chan TA; Yu H; Eng C; Pieper AA; Cheng F
    Aging Cell; 2022 Feb; 21(2):e13544. PubMed ID: 35023286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune cell residency in the nasal mucosa may partially explain respiratory disease severity across the age range.
    Winkley K; Banerjee D; Bradley T; Koseva B; Cheung WA; Selvarangan R; Pastinen T; Grundberg E
    Sci Rep; 2021 Aug; 11(1):15927. PubMed ID: 34354210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.
    Severa M; Diotti RA; Etna MP; Rizzo F; Fiore S; Ricci D; Iannetta M; Sinigaglia A; Lodi A; Mancini N; Criscuolo E; Clementi M; Andreoni M; Balducci S; Barzon L; Stefanelli P; Clementi N; Coccia EM
    PLoS Pathog; 2021 Sep; 17(9):e1009878. PubMed ID: 34473805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cell degranulation-triggered by SARS-CoV-2 induces tracheal-bronchial epithelial inflammation and injury.
    Cao JB; Zhu ST; Huang XS; Wang XY; Wu ML; Li X; Liu FL; Chen L; Zheng YT; Wang JH
    Virol Sin; 2024 Apr; 39(2):309-318. PubMed ID: 38458399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
    Matic S; Popovic S; Djurdjevic P; Todorovic D; Djordjevic N; Mijailovic Z; Sazdanovic P; Milovanovic D; Ruzic Zecevic D; Petrovic M; Sazdanovic M; Zornic N; Vukicevic V; Petrovic I; Matic S; Karic Vukicevic M; Baskic D
    PLoS One; 2020; 15(12):e0241097. PubMed ID: 33382687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On Deep Landscape Exploration of COVID-19 Patients Cells and Severity Markers.
    Vázquez-Jiménez A; Avila-Ponce De León UE; Matadamas-Guzman M; Muciño-Olmos EA; Martínez-López YE; Escobedo-Tapia T; Resendis-Antonio O
    Front Immunol; 2021; 12():705646. PubMed ID: 34603282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.
    Ravindra NG; Alfajaro MM; Gasque V; Huston NC; Wan H; Szigeti-Buck K; Yasumoto Y; Greaney AM; Habet V; Chow RD; Chen JS; Wei J; Filler RB; Wang B; Wang G; Niklason LE; Montgomery RR; Eisenbarth SC; Chen S; Williams A; Iwasaki A; Horvath TL; Foxman EF; Pierce RW; Pyle AM; van Dijk D; Wilen CB
    PLoS Biol; 2021 Mar; 19(3):e3001143. PubMed ID: 33730024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19.
    Shi W; Liu X; Cao Q; Ma P; Le W; Xie L; Ye J; Wen W; Tang H; Su W; Zheng Y; Liu Y
    Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L84-L98. PubMed ID: 33146564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological characterization and comparison of children with COVID-19 from their adult counterparts at single-cell resolution.
    Jia R; Li Z; Hu S; Chang H; Zeng M; Liu P; Lu L; Xu M; Zhai X; Qian M; Xu J
    Front Immunol; 2024; 15():1358725. PubMed ID: 39148728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19.
    Hou Y; Zhou Y; Gack MU; Lathia JD; Kallianpur A; Mehra R; Chan TA; Jung JU; Jehi L; Eng C; Cheng F
    Signal Transduct Target Ther; 2021 Jul; 6(1):292. PubMed ID: 34330889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type I and III interferon responses in SARS-CoV-2 infection.
    Kim YM; Shin EC
    Exp Mol Med; 2021 May; 53(5):750-760. PubMed ID: 33953323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
    Roukens AHE; Pothast CR; König M; Huisman W; Dalebout T; Tak T; Azimi S; Kruize Y; Hagedoorn RS; Zlei M; Staal FJT; de Bie FJ; van Dongen JJM; Arbous SM; Zhang JLH; Verheij M; Prins C; van der Does AM; Hiemstra PS; de Vries JJC; Janse JJ; Roestenberg M; Myeni SK; Kikkert M; Yazdanbakhsh M; Heemskerk MHM; Smits HH; Jochems SP; ;
    Nat Immunol; 2022 Jan; 23(1):23-32. PubMed ID: 34937933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells.
    Stanifer ML; Kee C; Cortese M; Zumaran CM; Triana S; Mukenhirn M; Kraeusslich HG; Alexandrov T; Bartenschlager R; Boulant S
    Cell Rep; 2020 Jul; 32(1):107863. PubMed ID: 32610043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients.
    Ni L; Cheng ML; Feng Y; Zhao H; Liu J; Ye F; Ye Q; Zhu G; Li X; Wang P; Shao J; Deng YQ; Wei P; Chen F; Qin CF; Wang G; Li F; Zeng H; Dong C
    Front Immunol; 2021; 12():603563. PubMed ID: 33603759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 infection activates a subset of intrinsic pathways to inhibit type I interferons
    Luo W; Huang L; Wang X; Ma Y; Xiao J; Song X; Liu P; Wang Y; Wang Y; Ren Z
    Int J Med Sci; 2021; 18(12):2561-2569. PubMed ID: 34104087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.